Skip to content
Disclosery

EXANE DERIVATIVES: IVE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on IVE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 IVE shares at 2022-03-31 per its 13F-HR filed 2022-04-22.

the latest 13F is the newest step

  1. period ended2022-03-31
    13F 0 shares
    Change vs previous 13F -52,550 shares

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-12-31
    13F 52,550 shares
    Change vs previous 13F +44,148 shares

    2% of the 13F portfolio, value $8,230,608.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 8,402 shares
    Change vs previous 13F -50,572 shares

    0.3% of the 13F portfolio, value $1,221,775.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 58,974 shares
    Change vs previous 13F +23,528 shares

    2.05% of the 13F portfolio, value $8,732,670.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 35,446 shares
    Change vs previous 13F not available

    1.51% of the 13F portfolio, value $5,006,172.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).